CN1235545A - 含有氯雷他定和减充血剂的用于治疗哮喘的组合物 - Google Patents

含有氯雷他定和减充血剂的用于治疗哮喘的组合物 Download PDF

Info

Publication number
CN1235545A
CN1235545A CN97199404A CN97199404A CN1235545A CN 1235545 A CN1235545 A CN 1235545A CN 97199404 A CN97199404 A CN 97199404A CN 97199404 A CN97199404 A CN 97199404A CN 1235545 A CN1235545 A CN 1235545A
Authority
CN
China
Prior art keywords
loratadine
pseudoephedrine
described method
patient
decongestant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97199404A
Other languages
English (en)
Chinese (zh)
Inventor
A·G·哈里斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1235545A publication Critical patent/CN1235545A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN97199404A 1996-10-31 1997-10-29 含有氯雷他定和减充血剂的用于治疗哮喘的组合物 Pending CN1235545A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
US08/739,669 1996-10-31

Publications (1)

Publication Number Publication Date
CN1235545A true CN1235545A (zh) 1999-11-17

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199404A Pending CN1235545A (zh) 1996-10-31 1997-10-29 含有氯雷他定和减充血剂的用于治疗哮喘的组合物

Country Status (21)

Country Link
EP (1) EP0941091A1 (sk)
JP (1) JP2000505104A (sk)
KR (1) KR20000052922A (sk)
CN (1) CN1235545A (sk)
AR (1) AR008908A1 (sk)
AU (1) AU731756B2 (sk)
BR (1) BR9712705A (sk)
CA (1) CA2268546A1 (sk)
CO (1) CO4910128A1 (sk)
CZ (1) CZ150999A3 (sk)
HU (1) HUP9904075A3 (sk)
ID (1) ID23431A (sk)
IL (1) IL129662A0 (sk)
NO (1) NO992062D0 (sk)
NZ (1) NZ335078A (sk)
PE (1) PE11399A1 (sk)
PL (1) PL333056A1 (sk)
SK (1) SK54599A3 (sk)
TR (1) TR199901003T2 (sk)
WO (1) WO1998018470A1 (sk)
ZA (1) ZA979731B (sk)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495100A (zh) * 2006-06-01 2009-07-29 先灵-普劳健康护理产品公司 包含去氧肾上腺素的缓释药物制剂
CN101081224B (zh) * 1999-12-20 2012-05-30 先灵公司 稳定的缓释口服给药组合物
CN101134038B (zh) * 1999-12-20 2013-11-06 默沙东公司 缓释的口服给药组合物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
MXPA03011705A (es) * 2001-06-20 2004-03-19 Schering Corp Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal.
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101081224B (zh) * 1999-12-20 2012-05-30 先灵公司 稳定的缓释口服给药组合物
CN101134038B (zh) * 1999-12-20 2013-11-06 默沙东公司 缓释的口服给药组合物
CN101495100A (zh) * 2006-06-01 2009-07-29 先灵-普劳健康护理产品公司 包含去氧肾上腺素的缓释药物制剂

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
HUP9904075A3 (en) 2002-02-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (es) 2000-04-24
CZ150999A3 (cs) 1999-10-13
KR20000052922A (ko) 2000-08-25
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
JP2000505104A (ja) 2000-04-25
PE11399A1 (es) 1999-02-09
CA2268546A1 (en) 1998-05-07
AR008908A1 (es) 2000-02-23
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (id) 2000-04-20
TR199901003T2 (xx) 1999-07-21
NO992062L (no) 1999-04-29
SK54599A3 (en) 2000-08-14
AU4995397A (en) 1998-05-22
PL333056A1 (en) 1999-11-08
IL129662A0 (en) 2000-02-29
NO992062D0 (no) 1999-04-29

Similar Documents

Publication Publication Date Title
CN1235545A (zh) 含有氯雷他定和减充血剂的用于治疗哮喘的组合物
Grant et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial
Craps et al. Clinical investigation of agents with prophylactic anti‐allergic effects in bronchial asthma
Aaronson Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma
US6086914A (en) Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity
Condemi et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
AU740504B2 (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo
Simons et al. Clinical pharmacology of H1-antihistamines
Beswick et al. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis
Georgitis et al. Ipratropium bromide nasal spray in non‐allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life
Gonzalez et al. Inhibition of airway reactivity by nifedipine in patients with coronary artery disease
Allegra et al. Cetirizine for seasonal allergic rhinitis in children aged 2‐6 years
Farmer et al. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the EasibreatheTMinhaler for the treatment of paediatric asthma
Groseclaude et al. Cetrizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis
Sessler Poor tolerance of oral activated charcoal with theophylline overdose
Ratner et al. Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis
AU749169B2 (en) A method for preventing the onset of asthma
MXPA99003936A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
EP1569650B1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis
White et al. Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare
McDonald et al. Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction
JP2004534820A (ja) 鼻うっ血および鼻閉塞の処置のための抗ヒスタミン薬
Cazzola et al. Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma
Tristram et al. A comparison of oral astemizole with topical sodium cromoglycate in the treatment of hay fever
Stradling et al. Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler®) for the treatment of adult asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication